Crystal Bridge Announces Receipt by Alpha Cognition of Japanese Patent for Alzheimer Drug Alpha-1062 and Announces Private Placement Updates

Posted on 2021.02.27 by mertzjp

This entry was posted in Mertzholdings News. Bookmark the permalink.